Mafalda Antunes-Ferreira
Overview
Explore the profile of Mafalda Antunes-Ferreira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Glogovitis I, DAmbrosi S, Antunes-Ferreira M, Chiogna M, Yahubyan G, Baev V, et al.
Noncoding RNA
. 2025 Feb;
11(1).
PMID: 39997617
Liquid biopsy has gained significant attention as a non-invasive method for cancer detection and monitoring. IsomiRs and tRNA-derived fragments (tRFs) are small non-coding RNAs that arise from non-canonical microRNA (miRNAs)...
2.
Eslami-S Z, Cortes-Hernandez L, Glogovitis I, Antunes-Ferreira M, DAmbrosi S, Kurma K, et al.
Front Cell Dev Biol
. 2023 Aug;
11:1209846.
PMID: 37601099
Platelets are active players in hemostasis, coagulation and also tumorigenesis. The cross-talk between platelets and circulating tumor cells (CTCs) may have various pro-cancer effects, including promoting tumor growth, epithelial-mesenchymal transition...
3.
Antunes-Ferreira M, DAmbrosi S, Arkani M, Post E, In t Veld S, Ramaker J, et al.
Sci Rep
. 2023 Jun;
13(1):9359.
PMID: 37291189
Liquid biopsy approaches offer a promising technology for early and minimally invasive cancer detection. Tumor-educated platelets (TEPs) have emerged as a promising liquid biopsy biosource for the detection of various...
4.
DAmbrosi S, Giannoukakos S, Antunes-Ferreira M, Pedraz-Valdunciel C, Bracht J, Potie N, et al.
Int J Mol Sci
. 2023 Mar;
24(5).
PMID: 36902312
Despite the diversity of liquid biopsy transcriptomic repertoire, numerous studies often exploit only a single RNA type signature for diagnostic biomarker potential. This frequently results in insufficient sensitivity and specificity...
5.
In t Veld S, Arkani M, Post E, Antunes-Ferreira M, DAmbrosi S, Vessies D, et al.
Cancer Cell
. 2022 Sep;
40(9):999-1009.e6.
PMID: 36055228
Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for...
6.
DAmbrosi S, Visser A, Antunes-Ferreira M, Poutsma A, Giannoukakos S, Sol N, et al.
Cancers (Basel)
. 2021 Sep;
13(18).
PMID: 34572871
Tumor-educated Platelets (TEPs) have emerged as rich biosources of cancer-related RNA profiles in liquid biopsies applicable for cancer detection. Although human blood platelets have been found to be enriched in...
7.
Antunes-Ferreira M, Koppers-Lalic D, Wurdinger T
Mol Oncol
. 2020 Nov;
15(6):1727-1743.
PMID: 33219615
Nucleic acids and proteins are shed into the bloodstream by tumor cells and can be exploited as biomarkers for the detection of cancer. In addition, cancer detection biomarkers can also...